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Summary 
The physiological functions of the mouse telomeric major histocompatibility complex (MHC) 
class I molecules, including Hmt, are unknown. Hmt presents a polymorphic, N-formylated 
peptide encoded by the mitochondrial gene ND1 forming the cell surface maternally transmitted 
antigen (Mta).  Because the N-formyl moiety is required for Hmt binding, we proposed that 
Hmt may function generally in presentation of N-formylated antigens. This hypothesis was validated 
by a competitive binding assay, demonstrating that synthetic N-formyl peptides from other 
mitochondrial genes also bound Hmt. Bacteria similarly initiate protein synthesis with N-formy- 
lmethionine; indeed,  we  established  that  Hmt  can  also  present prokaryotic peptides in  an 
N-formyl-dependent manner. These results indicate biochemical specialization  of this MHC- 
peptide interaction and suggest a unique role for Hmt in prokaryotic host defenses. 
M 
ouse MHC class I genes are classified into two groups, 
the polymorphic H-2 K, D, and L genes, located in 
the centromeric segment of the H-2 complex (1, 2), and the 
more numerous and less polymorphic "nonclassical" telomeric 
genes encoded in the H-2 Q, T, and M  (formerly Qa-Tla- 
Hmt) regions (2). While products of the former are known 
to bind and present antigens to CD8 + T cells (3), the func- 
tion(s) of the latter genes are unknown (4). These nonclas- 
sical MHC class I genes could provide a repository of genetic 
diversity available to the H-2 K, D, and L regions through 
gene conversion or could be evolutionary remnants devoid 
of function (1, 3). Alternatively, their products could play 
a role in differentiation, immune regulation, or antigen pre- 
sentation (5). Computer-aided modeling suggested that the 
structure of the telomeric class I molecules resembles  that 
of HLA-A2, including a possible  peptide binding site (6). 
Two such molecules, Qa-1 (7) and Hint (8-10),  can present 
synthetic peptides to T cells, and several nonclassical MHC 
molecules can stimulate alloreactive MHC class I response 
(11, 12). However, these observations did not suggest a specific 
physiological role for the nonclassical MHC class I molecules. 
We previously demonstrated that the product of one of 
these genes, Hmt, presents an N-formylated, mitochondri- 
ally encoded peptide (designated Mtf) to antigen-specific CTL, 
thereby forming the maternally transmitted antigen (Mta) 
(8).  Mtf  itself  derives  from  the  NH2  terminus  of  the 
mitochondrially encoded NADH dehydrogenase subunit 1 
(ND1) (8-10).  The alleles of Mtf (o~, 3, 7, and 8) that ac- 
count for the polymorphism of Mta (designated a, b, c, and 
d) differ at codon 6 of NDI  (10). The most common allelic 
product, Mtf%  contains isoleucine in position six,  while 
Mtf~  contains  alanine.  When  bound  to  Hmt  and  32- 
microglobulin these two peptides are recognized by Mta  a- 
and Mtab-specific CTLs, respectively. Moreover,  the exoge- 
nous addition of synthetic Mtf  ~ to cells expressing Hint and 
endogenous Mtf0 sensitizes  them to lysis by Mtaa-specific 
CTLs (8,  9). 
The exclusive presentation of Mtf by Hmt and the failure 
to detect other examples of Hmt-restriction suggested that 
unique biochemical properties of mitochondrially encoded 
peptides might favor presentation by Hmt (8, 13). Most ob- 
viously, mitochondrial, but not cytoplasmic, protein synthesis 
is initiated with N-formylmethionine (14). Indeed, N-formy- 
lated ND1 synthetic peptides, but not N-acetylated or non- 
substituted analogs, were shown to bind to Hint (8, 9). Inas- 
much as bacteria also initiate protein synthesis with N-formy- 
lmethionine, it further seemed plausible that Hmt might func- 
tion in selective presentation of N-formyl-peptides derived 
from prokaryotic organisms. 
Materials and Methods 
Peptide Synthesis.  Peptides  in Table 1 were synthesized  by solid- 
phase on a peptide synthesizer (430A; Applied Biosystems, Foster 
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purity by reverse-phase HPLC and amino acid analysis (Pico Tag 
system; Waters Associates, Milford, MA); several  peptides were also 
analyzed  by NH2-terminal  amino acid sequence  analysis (477A 
Protein Sequencing  System; Applied  Biosystems). 
Cytotoxic T Lympkocytes.  CTL clone 1D3 specific for Mta  ~  was 
generated as described (8) by immunizing Mta  b (NZB 9  x  BALB/c 
o') F1 mice with BALB/c  (Mta  a) spleen cells. Restimulation in 
vitro and maintenance were as described earlier (8). 
Competition Assay.  Target cells of the WEHI-105.7 NZB thy- 
moma (H-2  d, Mta  b) were labeled with SlCr, washed four times, 
and incubated for 75 rain at 37~  with increasing concentrations 
of the indicated peptides  in  the presence  of 50  nM fNDll-12. 
Target  cells were  washed  twice before  incubation  with  Mta  ~- 
specific CTL clone  1D3  in  a  4-h  SlCr release assay, using  an 
effector to target (E/T) cell ratio of 20:1. Percent specific lysis was 
calculated as described previously  (8). 
Results  and Discussion 
To examine binding of diverse peptides to Hmt we estab- 
lished a peptide competition assay. Whereas a six amino acid 
formyl peptide derived from ND1 (fNDll-6; Table 1) defined 
the minimum sequence for sensitization of target cells for 
Mta-specific lysis (8), a formylated five amino acid ND1 pep- 
tide (fNDlt-s) efficiently competed for Hint binding. Con- 
sequently, fNDll-s blocked target cell sensitization (Fig. 1) 
by such sensitizing peptides as fNDll-12.  The competition 
by fND11-s could be reversed by increasing concentrations 
of antigenic peptide. This pattern of inhibition was seen with 
all  Mta-specific  CTLs  tested.  Neither  nonsubstituted  nor 
N-acetylated NBll-5 blocked target cell lysis (Table 1), con- 
firming the N-formyl requirement for Hmt binding. These 
results argue for competitive occupancy of a single binding 
site by both  sensitizing and blocking peptides. 
To test the hypothesis that Hmt could bind NH2-terminal 
bacterial peptides,  we first mediated ND1  peptides with a 
positively-charged lysine residue to simulate typical prokaryotic 
signal peptides (15). Despite the introduction of this charged 
residue, such peptides also efficiently blocked Mta-specific cy- 
tolysis (Fig. 2, A). To evaluate whether an N-formyl group 
was a general requirement for Hmt-peptide interactions or 
only reflected the peculiarities of ND1  and its analogs, we 
examined whether  other  synthetic mitochondrial peptides 
could  block  fNDll-12  induced  lysis.  One  such  peptide, 
fND21-12 (Fig. 2 B), did not inhibit.  In contrast, fND41-12 
and fND51-12  peptides efficiently competed for binding of 
Table  1.  Synthetic Peptides Used in Competition Assays 
Peptide  designation  Sequence  ICs0 
Mitochondrial peptides 
ND11_s t 
NDll-6 
NDl1_12 
NDIH2/K2 
NDIH2/z3 
ND21-12 
ND41-12 
ND51-12 
Nonmitochondrial  peptides 
E. coli amp-C /~-Lactamase  (Amp-C) II 
B. cereus bla-z 3-Lactamase (Bla-z) 
E. coli ribosomal protein L25 (L25) 
V.  haweyi alkanal monooxygenase (VHAM) 
V. anguillarum membrane associated protein (VAMAP) 
C.  nephridii thioredoxin C-2  (CNTC) 
/~M* 
MFFIN  <0.2 
MFFINI  NAS 
MFFINILTLLVP  NA 
MKFINILTLLVP  <2 
MFKINILTLLVP  <2 
MNPITLAIIYFT  >20 
MLKIILPSLMLL  <3 
MKVINIFTTSIL  <2 
MFKTTLCALLIT  <6 
MFVLNKFF  <0.1 
MFTINAEV  <3 
MKFGNFLL  >20 
MFKSTLNIAV  >20 
MMFKFALYFI  >20 
* ICs0: The formyl peptide concentration required for 50% inhibition of target lysis of cells sensitized with 50 nM of fNDlt_n.  Calculated ICs0 
are representative of three or more independent experiments. The nonsubstituted and N-acetylated  analogs of all peptides listed except ND21-12 were 
also tested and the IC50 of each was >20/zM. 
* Convention for mitochondrial peptides: NDll_s designates a nonsubstituted pentameric peptide of ND1 spanning residues 1 to 5; fND11_s and 
AcNDli_s are formylated  and acetylated  derivatives, respectively. ND11-12/K2 is a 12-mer ND1 peptide modified  by substitution of lysine in position 
2. ND21q2 denotes the NH2-terminal 12-mer peptide of the NADH dehydrogenase  subunit 2, etc. 
S NA: not applicable. Sensitizing peptides. 
Ir Designations of nonmitochondrial peptides. These sequence data are from the GenBank database; accession numbers of the precursor proteins are: 
Amp-C:A01007; Bla-Z:A27755; L25:R5EC25; VAHM:A22613; VAMAP:A29928; and CNTC:A29797. 
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increasing concentrations  of fNDll-12 in the presence of 1/~M fND11-s 
(I-]),  or increasing concentrations  of fNDll-s in the presence of 50 nM 
fNDll_12  (e).  Target cells were washed  twice before incubation  with 
Mta,-specific CTL clone 1D3 in a 4-h SlCr release assay, using an effector 
to target (E/T) call ratio of 20:1. 
fNDll-12 to Hint with an ICs0 of 1-3 #M (Fig.  2, C, and 
D).  Significantly,  neither  acetylated nor unmodified forms 
of ND41-12 or ND51-12 peptides blocked Mta-specific cytol- 
ysis. Preliminary experiments  indicate that  substitution of 
phenylalanine for proline in position 3 of fND21-12 similarly 
converts  this peptide  to an effective competitor. 
Finally, we examined whether Hmt could bind naturally 
occurring non-mitochondrial peptides in an N-formyl depen- 
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Figure 2.  ND1 analogs and mitochondrially-encoded peptides other than 
ND1 bind to Hint. Increasing concentrations  of the indicated peptides 
were added with 50 nM fNDll-12 to 51Cr-labeled WEHI-105.7 target cells 
for 75 rain. Target cells were incubated with Mtaa-specific clone 1D3 at 
a 20:1 E/T ratio. (A) NDll-lz/K2 and ND11_12/K3.  (B) ND21-12. (C) 
ND41q2. (D) ND51q2. 
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Figure 3.  Prokaryotic N-formylated  peptides compete  for binding to 
Hint. SlCr-release competition assay was performed as described in Fig. 
2. Peptide-pulsed WEHI 105.7 target cells (Mta  b) were incubated with 
Mtaa-specific CTL  clone  1D3  at  an  E/T  ratio  of 20:1. fND11-s  and 
AcNDlm-s were used as positive and negative controls,  respectively. (A) 
Bla-z.  (B) Amp-C.  (C) L25.  (D) CNTC and VHAM. 
dent fashion.  Six synthetic  peptides were chosen based on 
partial sequence similarity (25-50% including the first posi- 
tion) to ND1, ND4 or ND5 peptides.  NH2-terminal  pep- 
tides of Escherichia coli amp-C 3-1actamase, E. coli ribosomal 
protein  L25  and Bacillus cereus bla-z  3-1actamase (Table 1) 
blocked Mtaa-specific target cell lysis, exhibiting N-formyl 
dependent competitive binding to Hint (Fig. 3). Thus, Hmt 
binds a variety of formyl peptides including certain bacterial 
signal  sequences. 
The N-formyl group may be necessary, but it is not suf~dent 
for Hmt binding; three other N-formylated prokaryotic pep- 
tides did not block Mta-specific lysis. The signal sequences 
from Corynebacterium nephridii thioredoxin C-2 (CNTC), Vibrio 
anguillarum  membrane  associated protein  (VAMAP)  and 
V. harveyi alkanal monooxygenase (VHAM)  (Table 1),  did 
not block Mta~-specific target cell lysis (Fig. 3 and Table 1). 
Thus, as expected, we conclude that the binding cleft of Hmt 
contains important contact points other than those interacting 
with the formyl group. Although the Hmt-binding peptides 
in this study have no apparent motif or secondary structure, 
such might be inferred after a larger number of binding pep- 
tides has been investigated  (9). 
Hmt appears not to accommodate the extra methyl group 
of the N-acetyl moiety,  suggesting a tight formyl-peptide 
binding pocket within the peptide-binding cleft of Hint. These 
results are thus consistent with suggestions  by Schumacher 
et al.  (16) that peptide  termini are tightly associated with 
the cleft of class I molecules.  This pocket in Hmt seems to 
be evolutionarily conserved: Mta-specific CTLs reactive with 
the Mus  musculus domesticus  Mtf'* peptide  are  capable of 
lysing  cells derived from murid species as distantly related 
as M. caroli and M. dunni ("o16-20 million yr divergence time) 
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the T cell receptor interface of Hmt have maintained critical 
structures required for antigen-presentation  to T  cells. Mta  a- 
specific CTL, like typical H-2KDL-restricted CTL,  express 
or~f3 (9, 17) (TCR), rather than the 3'/5 TCR that have been 
associated with some CTL responses restricted by telomeric 
H-2 molecules (7, 11, 12). It remains to be established whether 
the V~ or VO segments used by the receptors are diverse or 
limited. 
The immune system must balance the need to present for- 
eign antigen with the need to avoid autoimmunity. Through 
a binding preference for N-formyl peptides, Hint may em- 
ploy an immunological strategy distinct from the generalist 
strategy of the H-2 KDL antigens. By focusing on N-formyl 
termini,  Hint may selectively present peptides derived from 
prokaryotic parasites  (8, 13) while ignoring the vast majority 
of self antigens;  this leaves only the autoimmune response 
to mitochondrial  antigens to be handled by clonal deletion 
or suppression.  As prokaryotic N-formylated peptides associate 
in vitro with Hmt,  it may be possible to detect an Hmt- 
restricted CTL response by mice immunized with such pep- 
tides or infected with intracellular pathogens. Alternatively, 
but not exclusively,  Hmt  may subserve important  nonim- 
munological functions. These could include transport from 
the cytoplasm to the exterior of the cell of hydrophobic for- 
mylated mitochondrial signal peptides, cleaved after insertion 
through  the mitochondrial  membrane. 
Other nonclassical MHC molecules may, like Hmt, dis- 
play a greater specialization of peptide binding than do the 
classical MHC molecules. As stable surface expression of class 
I MHC molecules appears to require peptide binding (9), selec- 
tive binding could explain why the telomeric MHC mole- 
cules are poorly represented on the cell surface.  Such special- 
ization could similarly explain the limited polymorphism of 
nonclassical MHC molecules. 
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